Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.22% | 16.98% | 6.03% | 17.81% | 17.32% |
| Total Depreciation and Amortization | -60.00% | -34.18% | -10.20% | 14.05% | -1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.71% | -251.28% | -77.50% | 230.00% | 381.25% |
| Change in Net Operating Assets | -5.37% | -2.04% | -8.57% | -30.28% | -25.86% |
| Cash from Operations | 225.45% | 551.52% | -189.19% | -28.57% | 12.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -37.91% | -23.36% | 4.04% | -6.61% | -16.20% |
| Total Debt Repaid | 44.09% | 0.20% | 67.32% | 27.27% | 14.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.44% | -444.44% | 154.17% | 507.69% | -5.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.47% | 198.08% | 138.55% | 116.28% | 8.75% |